Disruption of finely-coordinated neuropeptide signals in the hypothalamus can result in altered food intake and body weight. We identified neuron-derived neurotrophic factor (Nenf) as a novel secreted protein through a large scale screen aimed at identifying novel secreted hypothalamic proteins that regulate food intake. We observed robust Nenf expression in hypothalamic nuclei known to regulate food intake, and its expression was altered under the diet-induced obese (DIO) condition relative to the fed state.
INTRODUCTION

2
Energy homeostasis involves finely-tuned coordination of signals arising from 3 both peripheral sources and the central nervous system (CNS) to establish a well-4 balanced homeostatic feedback loop. Hypothalamic neuropeptides and other secreted 5 proteins play a critical role in modulating body weight and food intake. Lesions of the 6 lateral nuclei of the hypothalamus result in anorexia, and while lesions of both the 7 ventromedial (VMH) or paraventricular nuclei (PVN) result in excessive food intake and 8 body weight gain (3, 22) . Further, disruption of hypothalamic neuropeptide signals (e.g., 9
brain-derived neurotrophic factor; Bdnf, Agouti-related protein; Agrp) in loss-of-function 10 mouse models can lead to metabolic diseases and obesity (48, 63) . 11
Neurotrophic factors act as neuromodulators to maintain growth, survival, and 12 differentiation of neurons (24, 49) . Genetic evidence implicates the BDNF signaling 13 pathway in regulating feeding and body weight. A missense mutation in the BDNF 14 receptor, Tyrosine kinase receptor B (TRKB), has been identified in severely obese 15 children (19, 59) . Additionally, postnatal Bdnf deletion and haploinsufficiency both 16 produce hyperphagia and obesity in mice (17, 46) . Further, mice lacking the 17 melanocortin-4 receptor (Mc4r) exhibit excessive weight gain, and Bdnf has been shown 18 to be a downstream effector by which Mc4r signaling modulates energy balance (6, 58) . 19
Thus, the Bdnf/trkB signaling pathway contributes toward maintaining energy 20 homeostasis in the CNS, and its disruption results in increased susceptibility to obesity. 21
To discover novel regulators of feeding and body weight, we conducted a large-22 scale experimental and bioinformatic screen for hypothalamic factors that may signal 23 downstream of Bdnf/trkB to regulate food intake and body weight. Several characteristics 24 prompted us to select one candidate protein from this screen for in-depth characterization, 25
Neuron-derived Neurotrophic Factor (Nenf or neudesin). Mouse Nenf contains 171 26 amino acids, is 91% similar to human NENF, is primarily expressed in neurons, but is 27 absent from glia (31). In addition, it is expressed in white adipose tissue (28). Nenf is a 28 secreted heme-binding protein with neurotrophic and neuroprotective activities, and 29 possesses the ability to suppress adipocyte differentiation (28-31). However, a role for 30 NENF in energy balance has not yet been explored. 31 We show here that BDNF signaling inversely regulates expression of NENF in 32 the CNS, and that melanocortin signaling also regulates Nenf mRNA expression in 33 response to food intake. Since increased levels of hypothalamic BDNF suppress food 34 intake and body weight and alter gene expression (13, 55), our findings suggest that 35 NENF may function as a downstream effector of the Bdnf/trkB pathway to influence 36 melanocortin signaling and appetite, and that this relationship is disrupted in DIO mice. 37
Indeed, central administration of recombinant NENF significantly increased Pomc and 38
Mcr4 mRNA expression. This phenomenon was not observed in DIO mice, suggesting 39 that overfeeding results in potential resistance to NENF signaling. These findings 40 demonstrate the power of the integrated approach used here to identify novel 41 development (9, 50) . Genes that appears to show stronger expression in hypothalamus 69 relative to other brain regions were then cross-checked against the SAGE Genie database 70 (http://cgap.nci.nih.gov/SAGE) to confirm enrichment in hypothalamus relative to both 71 other neuronal and non-neuronal tissues. Sequences of genes that showed prominent and 72 selective expression in adult hypothalamus where then screened for the presence of a 73 signal peptide (http://uswest.ensembl.org/index.html). The chromosomal locations of 74 putative secreted proteins were then checked against the human obesity gene map (41) to 75 ascertain whether they mapped to genomic regions that contain a QTL implicated in the 76 regulation of body composition or food intake. Potential function of the candidate 77 protein was checked against the PubMed database (http://www.ncbi.nlm.nih.gov) to 78 ensure that no previous study implicated the candidate proteins in appetite control. 79
The following five criteria were applied to further narrow candidates for 80 functional characterization: 1) enriched for expression in hypothalamic nuclei known to 81 regulate body composition, hunger, satiety, or the endocrine axis; 2) maps to the genomic 82 region containing a QTL implicated in the regulation of body composition or food intake; 83 3) contains a signal peptide sequence in the N-terminus for protein secretion, as our focus 84 is on identification of novel secreted neural proteins that regulate food intake; 4) shows 85 altered gene expression under fed, fasted, and diet-induced obese (DIO) conditions; and 86 "Fed" control mice (8 weeks of age, n=4) were given ad libitum access to water and 91 standard rodent chow. "Fasted" mice (8 weeks of age, n=4) were raised on a diet similar 92 to fed controls, but given access only to water for 24 hours prior to euthanasia. Diet-93 induced obese (DIO) mice (8 weeks of age, n=4) were provided a high-fat diet. The Fed 94 and DIO mice received no food for 2-hrs to prevent random consumption of a meal prior 95 to euthanasia, but were allowed access to water. 96
97
In Situ Hybridization 98
To generate an Nenf riboprobe for in situ hybridization (ISH), plasmid encoding 99 the Nenf cDNA was purified using a DNA miniprep kit according to manufacturer's 100 protocol (K2100-10, Invitrogen, Carlsbad, CA) and used as a template for in vitro 101 transcription. The Nenf riboprobe was synthesized with T3 RNA polymerase (Roche) for 102 2 hrs at 37 ºC and purified by LiCl precipitation. Brains were collected from ad libitum 103 fed mice, with food removed 2 hrs before tissue collection. Freshly-isolated brain tissues 104 were immediately frozen on dry ice in OCT compound, and then stored at -80 ºC. Frozen 105 tissue was cut into sections (25 µm thickness) using a cryostat (Microm, model HM550; 106 Thermo Scientific, Waltham, MA) and mounted onto Superfrost Plus slides (Fisher 107 Scientific, Pittsburgh, PA). ISH was performed as previously described with the 108 following modifications (10, 12 analysis, which generated a Ct value for the threshold cycle of each sample. The ΔCt 119 value was generated by normalizing the data to 18 S rRNA, or ΔΔCt generated by 120 normalizing the data to the control treatment. The primers used for qPCR are listed in 121 
TrkB Inhibition 148
Bdnf is expressed in the hypothalamus of the adult mouse brain (23), primarily in 149 the VMH with low expression levels in the dorsomedial hypothalamus (DMH), in the 150 arcuate nucleus (ARC), and at very low levels in the lateral hypothalamus (LH) (51, 55, 151 58) . Therefore, a knock-in allele containing a point mutation (F616A) in the trkB gene 152 was used to pharmacologically and temporally inhibit trkB signaling in mice via a highly 153 permeable and selective small molecule inhibitor, 1NMPP1(14). The treated group 154 received 1NMPP1 (80 µM) for 14 days via drinking water starting at 2 months of age. 155 1NMPP1 was subsequently removed to allow for reactivation of trkB singling after 156 chemical inhibition. ISH was conducted four months after treatment, as previously 157 described, to measure Nenf mRNA levels in the ARC of the hypothalamus; semi-158 quantitative differences were analyzed using densitometry with ImageJ(http://rsbweb.nih.gov/ij/), which was normalized to the background. Mice were fasted 2-160 hrs prior to collection of brain samples. 161
162
Stereotaxic Cannulation 163
Unilateral cannulas for infusion of proteins were implanted into the lateral 164 cerebral ventricle of C57BL/6J male mice (8 weeks of age, n=10), as described 165 previously (2). One week after surgery, the correct placement of cannula was verified as 166 previously described, with the following minor modifications: intracerebroventricular 167 with the intakes of body weight matched DIO mice (6 months old). Weight matching 217 provided a control for potential physiological changes arising from the phenotype 218 induced by body weight. All mice were fed their respective diets since weaning. At the 219 start of the dark cycle, baseline food intake was measured two weeks after surgery. 220
Recombinant mammalian NENF was injected at 12 nmol, and food intake was measured 221 at 1, 2, 4, and 24 hrs after injection of the vehicle at the start of the dark cycle, subtracting 222 spillage from the total amount of food consumed. One week after the food intake test, a 223 second injection of the mammalian recombinant NENF was administered via i.c.v, 6 hrs 224 before the dark cycle. Mice were not allowed access to food after this injection, and 225 hypothalami were collected three hours later. We recently conducted a microarray-based screen to identify genes that are 251 dynamically and/or selectively expressed in the developing and adult mouse 252 hypothalamus from embryonic (E) 10 to postnatal day (P) 42, and expression patterns for 253 1,200 genes were verified by ISH (50). This data set was used as a starting point to 254
identify secreted hypothalamic proteins that may play novel roles in regulating neural 255 pathways involved in control of food intake and metabolism. Further data were obtained 256 by analyzing the publically available gene expression data generated by the Allen Brain 257
Atlas consortium (38). In total, we identified 250 candidate genes that were prominently 258 and selectively expressed in adult hypothalamic nuclei known to regulate food intake, 259 body weight, and expression of relevant neuropeptide hormones. One candidate, NENF, 260 met all 5 criteria for candidates of interest and was explored in detail. 261
Changes in physiological state of energy balance regulate Nenf gene expression. 262 ISH indicated that Nenf mRNA is expressed primarily in the PVN of the 263 hypothalamus, with lower levels of expression in the hypothalamic ARC ( Figure 1 and 264 2E). We examined whether metabolic state affects expression levels of Nenf in the 265 hypothalamus. Indeed, Nenf, Bdnf and Pomc mRNA expression in the hypothalamus was 266 suppressed in the DIO, but not the fasted state ( Figure 1B, 1C signaling has been associated with the development of both obesity and anorexia (1, 4, 272 15, 18, 21, 26, 36, 37, 42-45, 47, 51-53) , we determined whether BDNF signaling 273 modulates Nenf mRNA expression. 274
Nenf mRNA levels are modulated by the BDNF signaling pathway. 275
To determine whether Nenf mRNA levels are regulated by the BDNF/trkB 276 signaling pathway, we administered recombinant BDNF protein through i.c.v injection 277 just before onset of the dark cycle. Importantly, central administration of BDNF does not 278 cause a conditioned taste aversion (55). An acute increase in BDNF levels in the brain 279 resulted in robust decrease in food intake just 1 hr later, and body weight decreased the 280 day after injection, relative to vehicle (Figure 2A We next sought to test whether transient inhibition of BDNF activity affects 287 hypothalamic Nenf mRNA levels. Mice homozygous for a targeted mutation of trkB, 288 which alters the highly-conserved phenylalanine at position 616 within the catalytic 289 kinase domain to alanine (F616A), enabled us examine the effects of selective and 290 reversible inhibition of trkB signaling on Nenf mRNA levels by using the synthetic 291 compound 1NMPP1 (8, 14) . 1NMPP1 is a highly membrane-permeable compound that 292 can be conveniently delivered in drinking water and readily crosses both the placental and 293 blood-brain barriers to reversibly regulate the activity of neuronal-expressed mutant trkB 294 (56). Therefore, 1NMPP1, or vehicle solution without 1NMPP1, was administered via 295 drinking water to 2-month-old mice for 14 days. Hypothalamic Nenf mRNA levels were 296 then characterized in both treatment groups at 4 months of age. Following inhibition of 297 trkB signaling at 2 months of age, mice at 4 months of age displayed a robust increase in 298 ARC Nenf mRNA levels via ISH ( Figures 2D and E, F 1,11 =29.43, P=0.0002) . 299 NENF administration inhibited food intake and decreased body weight. 300
To directly determine whether NENF could affect food intake and body weight, 301
we bacterially-produced recombinant NENF or two purified control proteins (CNTF and 302 GST) in mice weighing, on average, 25 g. In addition, recombinant NENF produced in 303 mammalian cells was injected as an additional control for bacterially-produced NENF. A 304 single dose of recombinant NENF protein, with the GST tag removed, was injected. 305
Central administration of 0.1, 1, 10, and 100 nmol doses of NENF significantly decreased 306 food intake ( Figure 3A- nmol dose was most efficacious, with decreased food intake at 0-1 hr ( Figure 3A) ; the 1, 316 10, and 100 nmol doses decreased food intake at 1-2 hrs, and all doses decreased food 317 intake at 2-4 and 4-22 hrs ( Figure 3B-D signaling, we hypothesized that NENF administration might be much less effective at 358 reducing food intake and body weight in DIO mice. Indeed, we failed to observe anychanges in food intake or body weight relative to vehicle-injected DIO mice when the 360 mammalian recombinant NENF was injected ( Figures 4A-C intake, rapid decreases in hypothalamic Nenf mRNA levels were observed. However, 426 changes in Bdnf, Nenf and Pomc mRNA levels were not observed after a 24-hour fast,suggesting that the duration of the fast may not have been the optimal duration to observe 428 gene expression changes (e.g. the fast was too long or not long enough). 429
Nenf is expressed in nuclei of the hypothalamus known to be involved in energy 430 regulation, and changes in diet (DIO mice) altered Nenf gene expression in the same 431 direction as Bdnf gene expression; thus, we predicted that NENF would inhibit food 432 intake. Indeed, central delivery of recombinant NENF decreased food intake and body 433 weight, suggesting that it is a novel anorexigenic neurotrophic factor. The dose of NENF 434 delivered via i.c.v. altered the duration of time until decreased food intake was observed, 435 with the highest dose (100 nmol) suppressing food intake by 1 hour and the lowest dose 436 (0.1 nmol) by 4 hours, relative to vehicle injected mice. However, the lower limit of 437 physiological detection for NENF did not fall into the range of doses delivered, and 438 remains to be determined. 439 The DIO diet is high in fat and dense in energy, which may result in it being a 456 more palatable diet given the increased fat content relative to a standard chow diet. 457 Therefore, the high-fat diet fed to DIO mice may have altered reward cues associated 458 with food intake, relative to BWM mice fed a standard chow diet. Environmental factors 459 such as energy-density of the diet, palatability/taste, or large quantities of available food, 460 provide reward cues to reinforce and drive food intake behavior (7, 33, 62) . These reward 461 cues have been shown to weaken feedback signals, such as leptin, that serve to decrease 462 food intake and modulate whole-body energy balance (7, 62). Similar quantities of food 463 were provided to DIO and BWM mice daily. Therefore, the quantities of available food 464 most likely did not influence the reward cues between the two groups. However, the 465 energy density of the diet as well as palatability and/or taste differences between the diets 466 may have influenced the amount consumed between the two groups (DIO vs. BWM), 467 overriding the signals triggered by centrally administered recombinant NENF. Thus, it is 468 possible that the DIO mice have alterations in reward-driven food intake behavior (62). It 469 remains to be determined if NENF is less effective in altering energy balance when 470 reward-driven food intake is reinforced by components of the high-fat diet fed to the DIO 471 mice, relative to the standard chow fed to the BWM mice. 
